{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:01:34Z","timestamp":1775728894700,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","award":["Z-2\/CSP-25"],"award-info":[{"award-number":["Z-2\/CSP-25"]}],"id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["TWINSIGHT-09"],"award-info":[{"award-number":["TWINSIGHT-09"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12325-026-03520-8","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:28:30Z","timestamp":1772267310000},"page":"1790-1801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Joint Assessment Matters: Diagnostic and Therapeutic Benefits of Interdisciplinary Psoriasis Care"],"prefix":"10.1007","volume":"43","clinical-trial-number":[{"clinical-trial-number":"drks00037907","registry":"10.18810\/drks"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6158-9048","authenticated-orcid":false,"given":"Tassilo","family":"Dege","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Kiesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iana","family":"Bychkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Leichtfuss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Schulze-Hagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Goebeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Leipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Olsavszky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick-Pascal","family":"Strunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6421-9699","authenticated-orcid":false,"given":"Astrid","family":"Schmieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"10","key":"3520_CR1","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3899\/jrheum.171094","volume":"45","author":"PJ Mease","year":"2018","unstructured":"Mease PJ, Palmer JB, Liu M, Kavanaugh A, Pandurengan R, Ritchlin CT, et al. Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the Corrona Psoriatic Arthritis\/Spondyloarthritis Registry. J Rheumatol. 2018;45(10):1389\u201396. https:\/\/doi.org\/10.3899\/jrheum.171094.","journal-title":"J Rheumatol"},{"issue":"8","key":"3520_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3899\/jrheum.141598","volume":"42","author":"Y Ohara","year":"2015","unstructured":"Ohara Y, Kishimoto M, Takizawa N, Yoshida K, Okada M, Eto H, et al. Prevalence and clinical characteristics of psoriatic arthritis in Japan. J Rheumatol. 2015;42(8):1439\u201342. https:\/\/doi.org\/10.3899\/jrheum.141598.","journal-title":"J Rheumatol"},{"issue":"11","key":"3520_CR3","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s00105-022-05051-z","volume":"73","author":"P Staubach","year":"2022","unstructured":"Staubach P, Veelen K, Zimmer S, Sohn A, Lang BM, Peveling-Oberhag A, et al. Multidisciplinarity as the key to success: cooperation between dermatology and rheumatology to optimize patient care. Dermatologie (Heidelberg). 2022;73(11):866\u201371. https:\/\/doi.org\/10.1007\/s00105-022-05051-z.","journal-title":"Dermatologie (Heidelberg)"},{"issue":"2","key":"3520_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00296-015-3377-z","volume":"36","author":"T Cobo-Ib\u00e1\u00f1ez","year":"2016","unstructured":"Cobo-Ib\u00e1\u00f1ez T, Villaverde V, Seoane-Mato D, Mu\u00f1oz-Fern\u00e1ndez S, Guerra M, Del Campo PD, et al. Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review. Rheumatol Int. 2016;36(2):221\u20139. https:\/\/doi.org\/10.1007\/s00296-015-3377-z.","journal-title":"Rheumatol Int"},{"issue":"5","key":"3520_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40257-013-0032-x","volume":"14","author":"WH Boehncke","year":"2013","unstructured":"Boehncke WH, Menter A. Burden of disease: psoriasis and psoriatic arthritis. Am J Clin Dermatol. 2013;14(5):377\u201388. https:\/\/doi.org\/10.1007\/s40257-013-0032-x.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"3520_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","volume":"41","author":"S Gupta","year":"2021","unstructured":"Gupta S, Syrimi Z, Hughes DM, Zhao SS. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int. 2021;41(2):275\u201384. https:\/\/doi.org\/10.1007\/s00296-020-04775-2.","journal-title":"Rheumatol Int"},{"issue":"2","key":"3520_CR7","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2021.9111","volume":"14","author":"M Burlando","year":"2022","unstructured":"Burlando M, Craviotto C, Carmisciano L, Bianchi G, Parodi A. Four-years experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis. Dermatol Rep. 2022;14(2):9111. https:\/\/doi.org\/10.4081\/dr.2021.9111.","journal-title":"Dermatol Rep"},{"issue":"2","key":"3520_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.reuma.2016.03.005","volume":"13","author":"R Queiro","year":"2017","unstructured":"Queiro R, Coto P, Rodr\u00edguez J, Notario J, Nav\u00edo Marco T, de la Cueva P, et al. Multidisciplinary care models for patients with psoriatic arthritis. Reumatol Clin. 2017;13(2):85\u201390. https:\/\/doi.org\/10.1016\/j.reuma.2016.03.005. (PMID: 27068194).","journal-title":"Reumatol Clin."},{"issue":"6","key":"3520_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/ard-2024-225531","volume":"83","author":"L Gossec","year":"2024","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJO, Aletaha D, Baraliakos X, Bertheussen H, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis. 2024;83(6):706\u201319. https:\/\/doi.org\/10.1136\/ard-2024-225531.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3520_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jamadermatol.2020.5844","volume":"157","author":"E Carr","year":"2021","unstructured":"Carr E, Mahil SK, Brailean A, Dasandi T, Pink AE, Barker JN, et al. Association of patient mental health status with the level of agreement between patient and physician ratings of psoriasis severity. JAMA Dermatol. 2021;157(4):413\u201320.","journal-title":"JAMA Dermatol"},{"key":"3520_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-011-1172-6","volume-title":"Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic","author":"NF Velez","year":"2012","unstructured":"Velez NF, Wei-Passanese EX, Husni ME, Mody EA, Qureshi AA. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Berlin: Springer; 2012."},{"issue":"12","key":"3520_CR12","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1007\/s12325-023-02667-y","volume":"40","author":"JA von Ahnen","year":"2023","unstructured":"von Ahnen JA, Gross G, Lull C, Blauth M, Kraemer B, Olsavszky V, et al. The effect of an interdisciplinary dermatological\u2013rheumatological consultation on the outcome of patients with psoriasis with musculoskeletal pain: a prospective, single-center cohort study. Adv Ther. 2023;40(12):5243\u201353.","journal-title":"Adv Ther"},{"issue":"3","key":"3520_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13283","volume":"33","author":"E Theodorakopoulou","year":"2020","unstructured":"Theodorakopoulou E, Dalamaga M, Katsimbri P, Boumpas DT, Papadavid E. How does the joint dermatology\u2013rheumatology clinic benefit both patients and dermatologists? Dermatol Ther. 2020;33(3):e13283.","journal-title":"Dermatol Ther"},{"issue":"10","key":"3520_CR14","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s13555-024-01258-1","volume":"14","author":"PJ Mease","year":"2024","unstructured":"Mease PJ, Blauvelt A, Sima AP, Beaty SW, Low R, Gomez B, et al. Impact of disease factors of patients with psoriasis and psoriatic arthritis on biologic therapy switching: real-world evidence from the CorEvitas Psoriasis Registry. Dermatol Ther. 2024;14(10):2805\u201325.","journal-title":"Dermatol Ther"},{"key":"3520_CR15","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S478352","author":"V Patel","year":"2024","unstructured":"Patel V, Park SH, Zhong Y, Sima AP, Zhuo J, Roberts-Toler C, et al. The association between patient-reported disease burden and treatment switching in patients with plaque psoriasis treated with nonbiologic systemic therapy. Psoriasis Targets Ther. 2024. https:\/\/doi.org\/10.2147\/PTT.S478352.","journal-title":"Psoriasis Targets Ther"},{"key":"3520_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X241266727","volume":"16","author":"O Hen","year":"2024","unstructured":"Hen O, Harrison SR, De Marco G, Marzo-Ortega H. Early psoriatic arthritis: when is the right time to start advanced therapy? Ther Adv Musculoskelet Dis. 2024;16:1759720X241266727.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"3520_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-004062","volume":"10","author":"SVS Henkemans","year":"2024","unstructured":"Henkemans SVS, De Jong PH, Luime JJ, Kok MR, Tchetverikov I, Korswagen L-A, et al. Window of opportunity in psoriatic arthritis: the earlier the better? RMD Open. 2024;10(1):e004062.","journal-title":"RMD Open"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03520-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03520-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:14:09Z","timestamp":1775726049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03520-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3520"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03520-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tassilo Dege: Travel grants or speaker fees: Leo Pharma, Recordati Rare Diseases, Johnson & Johnson, Sanofi. Matthias Goebeler: Scientific advisory board\/ speakers bureau: Almirall, Argenx, Biotest, Fresenius, GSK, Janssen, Leo Pharma, Lilly, Novartis, UCB. Jan Leipe: research support\/ clinical trials: Abbott, Boehringer, Pfizer, Gilead, Novartis; Scientific advisory board\/ speakers of the bureau: Abbvie, Biogen, BMS, Galapagos, Lilly, medac, MSD, Novartis, Roche, Sanofi, UCB. Victor Olsavszky: Scientific advisory board\/ speakers of the bureau: BMS, Johnson & Johnson, and UCB.Patrick-Pascal Strunz: Research support: Novartis, Abbvie, and Chugai. Travel grants or speeker fees: Abbvie, UCB, Janssen, Novartis. Astrid Schmieder: research support\/ clinical trials: Abbvie, Boehringer-Ingelheim, Celgene, Eli Lilly, Janssen-Cilag, LEO Pharma, Merck, Novartis, Pfizer; Scientific advisory board\/ speakers bureau: Abbvie, Almirall, Hermal, Janssen, LEO, and Novartis, UCB. Oliver Steffens,\u00d6zlem Kiesel, Iana Bychkova, Theresa Schulze-Hagen, Marc Schmalzing, Caroline Glatzel and Lara Leichtfuss have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of the University of W\u00fcrzburg (reference no. 129\/22) and of the Medical Faculty Mannheim, Heidelberg University (reference no. 2022-502). All participants provided written informed consent prior to enrollment. Participants received no compensation for their participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}